Segmented Nucleic Acids via Non-Nucleotide Linkers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The synthesis of long nucleic acids with two or more non-nucleotide linkers is inefficient, leading to challenges in manufacturing, purification, and analytical characterization, and existing methods result in high synthetic errors and off-target cleavage in gene editing applications.

Innovation Solution

A highly efficient chemical method for preparing segmented nucleic acids using non-nucleotide linkers, which are formed by chemical ligations and enhance the function of nucleic acids by altering secondary structures and introducing additional molecular interactions, including hydrogen bonds, and are used in conjunction with CRISPR-mediated gene editing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional synthesis methods are used for long nucleic acids with multiple non-nucleotide linkers, then the synthesis can be performed with existing techniques, but the synthesis efficiency is low and synthetic errors are high

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidsynthetic errors
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The nucleic acid is divided into multiple segments that are synthesized separately and then joined together through chemical ligation. This segmentation approach allows each segment to be synthesized with high precision using conventional methods, while the overall assembly achieves high efficiency through parallel processing and modular construction, resolving the contradiction between synthesis efficiency and manufacturing precision.

Inventive Principle:
Principle #1Segmentation

2Ease of manufacture

If non-nucleotide linkers are introduced to replace phosphate diester bonds, then manufacturing cost is reduced and chemical modifications are enabled, but synthesis methods become more complex and challenging

Engineering Contradiction:
Improvemanufacturing costVSAvoidsynthesis complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

Chemical linkers serve as intermediary components that connect nucleic acid segments through well-established chemical ligation reactions. These linkers provide standardized interfaces with defined chemistry, enabling modular assembly while maintaining synthetic tractability. The intermediary nature of the linkers allows for systematic optimization of synthesis protocols, reducing overall complexity despite the introduction of non-standard components.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Device complexity

If long nucleic acids are synthesized as single continuous strands, then the structure is simple, but purification and analytical characterization become challenging due to secondary structures

Engineering Contradiction:
Improvestructural simplicityVSAvoidpurification difficulty
Core Design Contradiction:
Device complexityVSDifficulty of detecting and measuring

Solution Approach 1:

By synthesizing the nucleic acid as separate segments that are subsequently ligated, the method enables purification of individual segments before assembly. This segmentation strategy simplifies purification and analytical characterization at each stage, as shorter segments form fewer complex secondary structures compared to the full-length continuous strand. The final assembled structure achieves the desired functionality while maintaining synthetic and analytical tractability.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables cost-effective, high-quality production of segmented nucleic acids with reduced synthetic errors, improved stability, and targeted delivery, enhancing the efficacy and selectivity of gene editing therapies.

Implementation Method 1

non-nucleotide linkers formed by chemical ligations

Methodology Applied
Scientific EffectChemical ligation: Chemical Bonding

Implementation Method 2

introducing additional molecular interactions including hydrogen bonds

Methodology Applied
Scientific EffectHydrogen bonds:

Data Source

PatentUS20230167441A1Segmented Nucleic Acids
Publication Date: 2023.06.01 ZHONG MINGHONG
  • US20230167441A1 patent drawing
  • US20230167441A1 patent drawing
  • US20230167441A1 patent drawing

AI summary

Provided herein are processes and methods for preparation of segmented nucleic acids and segmented nucleic acid conjugates comprising at least two non-nucleotide linkers, and their RNP complexes with RNA guided gene editing proteins including CRISPR Cas proteins and ADAR enzymes. Also disclosed are the uses of the compositions comprising segmented nucleic acids or segmented nucleic acid conjugates as medicinal agents for treatment of diseases.